Oncolytics Biotech
ONCY
#9263
Rank
S$0.13 B
Marketcap
S$1.22
Share price
-4.78%
Change (1 day)
3.78%
Change (1 year)

Oncolytics Biotech (ONCY) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.77 Million

According to Oncolytics Biotech 's latest financial reports the company's total debt is S$0.77 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Oncolytics Biotech - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$1 M139.28%
2023-12-31S$0.42 M14.3%
2022-12-31S$0.36 M-46.96%
2021-12-31S$0.69 M66.56%
2020-12-31S$0.41 M-20.18%
2019-12-31S$0.52 M
2018-12-31N/A
2006-12-31S$0.19 M-7.91%
2005-12-31S$0.21 M5.29%
2004-12-31S$0.2 M3.7%
2003-12-31S$0.19 M19.22%
2002-12-31S$0.16 M-5.46%
2001-12-31S$0.17 M0.45%
2000-12-31S$0.17 M0.21%
1999-12-31S$0.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Aeterna Zentaris
AEZS
S$2.18 M 181.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$55.11 B 7,087,806.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$66.17 B 8,510,903.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$22.13 B 2,846,794.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
S$50.15 M 6,349.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
S$65.11 M 8,274.60%๐Ÿ‡บ๐Ÿ‡ธ USA